Evidence map›Paper›PMID 18472012›Full record

ReviewBiochimie2009

Effect of lactoferrin on enteric pathogens.

Theresa J Ochoa, Thomas G Cleary

Registry-linked trialOpen access · greenAbstract readReview
In one paragraph

Review in Biochimie, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04432935 (Effect of Bovine Lactoferrin on Seroconversion Following Polio Vaccine Administration in Children), which is not on this map. Cited by 60 papers.

0numbers the graph read from it
0cells of the map it votes in
60citing papers in PubMed
6.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04432935 nacompletednot on this mapstarted 2020, after this paper: background citation

Effect of Bovine Lactoferrin on Seroconversion Following Polio Vaccine Administration in Children: A Randomized Control Trial

TypeinterventionalSponsorAga Khan UniversityRan2020 to 2022Enrolled468ConditionsPoliomyelitisArmsBovine Lactoferrin, Placebo Glucon D
3 · Its place in the literature

Who cites it

60 citing papers in PubMed, 153 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Lactoferrin concentration in breast milk of mothers of low-birth-weight newborns.Journal of perinatology : official journal of the California Perinatal Association · 2017
    Trial
  4. Trial
  5. Trial
  6. Trial
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Effect of Iron on Viral Infections.Food and environmental virology · 2025
    Review
  13. Review
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Theresa J OchoaUniversidad Peruana Cayetano Heredia, Instituto de Medicina Tropical, Lima, Peru. theresa.j.ochoa@uth.tmc.edu
Thomas G Cleary
Universidad Peruana Cayetano Heredia · PE

Funding

Randomonized controlled trial-lactoferrin prevention of diarrhea in childrenR01HD051716 · NICHD · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI CLEARY, THOMAS GEORGE · 2007 to 2010
$960k
Role of virulence heterogeneity in acute and presistent EPEC diarrheaK01TW007405 · FIC · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI OCHOA, THERESA J · 2006 to 2009
$433k
FIC NIH HHS 1K01TW007405FIC NIH HHS K01 TW007405NICHD NIH HHS R01 HD051716NICHD NIH HHS R01-HD051716
6 · The paper itself

Abstract

Much has been learned in recent years about the mechanisms by which breastfeeding improves child health and survival. However, there has been little progress in using these insights to improve pediatric care. Factors that are important for protecting the breast fed infant might be expected to decrease the adverse effects of weaning on diarrhea, growth, and development. Lactoferrin, an iron-binding protein with multiple physiological functions (anti-microbial, anti-inflammatory, and immunomodulatory), is one of the most important proteins present in mammalian milk. Protection against gastroenteritis is the most likely biologically relevant activity of lactoferrin. Multiple in vitro and animal studies have shown a protective effect of lactoferrin on infections with enteric microorganisms, including rotavirus, Giardia, Shigella, Salmonella and the diarrheagenic Escherichia coli. Lactoferrin has two major effects on enteric pathogens: it inhibits growth and it impairs function of surface expressed virulence factors thereby decreasing their ability to adhere or to invade mammalian cells. Thus, lactoferrin may protect infants from gastrointestinal infection by preventing the attachment by enteropathogens in the gut. Recently several clinical trials in children have started to address this issue. Whether lactoferrin can prevent a significant portion of diarrheal disease remains to be determined.

Indexed as

Diarrhea, InfantileEnterobacteriaceaeEnterovirusHumansInfantInfant, NewbornIntestinal Diseases, ParasiticLactoferrinLactoferrin

Identifiers

PMID18472012
PMCPMC2626156
OpenAlexW2110250867

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.